Search results
Government's coercion on coronavirus vaccines 'encouraged conspiracy theories', warns former...
KNDO - KNDU Tri-Cities· 14 hours agoSir Jacob Rees-Mogg has said the behaviour of the government to coerce people into having Covid-19 ...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 12 hours agoThe FDA has informed Moderna that it is working to conclude the review by the end of May...
These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital,...
Barrons.com· 2 hours agoNovavax stock surged after the vaccine maker signs a $1.2 billion licensing deal with France’s...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 9 hours ago, opens new tab respiratory syncytial virus (RSV) vaccine due to "administrative constraints" and...
Dow Jones Today: Stocks Mixed As Dow on Track To Extend Winning Streak to Eight Consecutive Sessions
Investopedia· 5 hours agoModerna (MRNA) slid 4% as the biotech’s effort to move beyond just a COVID-19 vaccine was stalled...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 10 hours agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 2 days agoAstraZeneca is withdrawing its COVID vaccine, the company has announced. (PA) Jakub Porzycki,...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 13 hours agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Researchers discover benefits of adding immune-boosting agent to personalized cancer vaccine
Medical Xpress· 1 day agoThe study, published in Nature Communications, found that pairing a personalized dendritic cell ...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize...
Benzinga· 17 hours agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Agreement provides patients with broader access to a